NCT03254875

Brief Summary

The aim of the study is to evaluate whether a screening-based individually tailored nurse navigator intervention compared to standard care significantly reduce psychological and physical symptoms among women being treated for breast cancer who had moderate-to-severe distress (score ≥ 7 on the distress thermometer).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
309

participants targeted

Target at P75+ for not_applicable breast-cancer

Timeline
Completed

Started Aug 2017

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 31, 2017

Completed
15 days until next milestone

Study Start

First participant enrolled

August 15, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 21, 2017

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
Last Updated

August 27, 2021

Status Verified

August 1, 2021

Enrollment Period

3.6 years

First QC Date

July 31, 2017

Last Update Submit

August 26, 2021

Conditions

Keywords

Breast cancer, Psychosocial intervention

Outcome Measures

Primary Outcomes (1)

  • Distress

    Distress Thermometer

    Change from baseline and to 6,12 months (mixed models)

Secondary Outcomes (72)

  • Distress

    Change from baseline to 6 months

  • Distress

    Change from baseline to 12 months

  • Distress

    Change from baseline to 18 months

  • Depression

    Change from baseline and to 3, 10, 18 weeks, 6,12,18 months (mixed models)

  • Depression

    Change from baseline and to 6 months

  • +67 more secondary outcomes

Other Outcomes (1)

  • Social support

    Baseline

Study Arms (2)

Intervention

EXPERIMENTAL

Individually tailored nurse navigation

Behavioral: Individually tailored nurse navigation

Control

NO INTERVENTION

Usual care

Interventions

The intervention consists of systematic report of symptoms to the nurse and up to six individual, manual-based, face-to-face or telephone nurse navigator sessions depending on individual needs.

Intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Newly diagnosed with breast cancer (i.e. prior to surgery), scheduled for breast cancer surgery at Section of Breast Surgery at Rigshospitalet, 18 years or above, Danish citizen, read, understand and speak Danish, female gender,signed written informed consent. Those who experience high psychological distress (score ≥ 7 on the distress thermometer) will enter the RCT whereas those who experience low psychological distress (score \< 7 on the distress thermometer) will be followed in an observational questionnaire study.

You may not qualify if:

  • no severe cognitive problems or dementia, no severe psychiatric disease requiring treatment, e.g. schizophrenia, alcohol or narcotic dependence,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rigshospitalet

Copenhagen, DK-2100, Denmark

Location

Related Publications (1)

  • Bidstrup PE, Johansen C, Kroman N, Belmonte F, Duriaud H, Dalton SO, Andersen KG, Mertz B. Effect of a Nurse Navigation Intervention on Mental Symptoms in Patients With Psychological Vulnerability and Breast Cancer: The REBECCA Randomized Clinical Trial. JAMA Netw Open. 2023 Jun 1;6(6):e2319591. doi: 10.1001/jamanetworkopen.2023.19591.

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Pernille Bidstrup, PhD

    Danish Cancer Society Research Center

    PRINCIPAL INVESTIGATOR
  • Christoffer Johansen, DMSc

    Rigshispitalet

    PRINCIPAL INVESTIGATOR
  • Birgitte Mertz, RN

    Rigshospitalet, Denmark

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Intervention status will be blinded in analyses.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: During a 2-year period, 758 patients newly diagnosed with breast cancer will be screened for inclusion at the Section of Breast Surgery at Rigshospitalet, Copenhagen. Of these 324 participants enter the RCT and are randomized in a computer-generated sequence of 1:1 to the intervention (nurse-navigation) or control group (standard care). A total of 432 participants will enter an observational questionnaire study. All participants are followed for 1,5 years.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, DMSc

Study Record Dates

First Submitted

July 31, 2017

First Posted

August 21, 2017

Study Start

August 15, 2017

Primary Completion

March 31, 2021

Study Completion

March 31, 2021

Last Updated

August 27, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations